{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/12447"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/12447","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Creation of a mouse model with consitutively activated RHEB (RAS Homologue enriched in brain) in adipose tissue","abstract":"According to the CDC, approximately one third of the adults in the United States are obese consequentially causing a rise in obesity related metabolic diseases such as diabetes type 2. Major catabolic and anabolic pathways become disregulated in obesity, causing problems in energy homeostasis. One major nutrient sensor that plays an essential role in energy homeostasis is mammalian target of rapamycin complex 1 (mTORC1). mTORC1 is necessary for the proper growth and development of adipocytes. It also regulates vital adipose tissue pathways like lipolysis and lipogenesis. Therefore our lab has focused much research into better understanding mTORC1 role in energy homeostasis and how it is affected in diseases states. Previous research in our lab, using 3T3-L1 adipocytes, discovered that mTORC1 decreases mRNA levels of the lipolytic enzymes adipose triglyceride lipase (ATGL) and hormone sensitive lipase (HSL). In order to get a better picture of mTORC1's role in lipid metabolism, we decided to create a mouse model with conditional expression of constitutively active Rheb (caRheb) in adipose tissue. As Rheb is the major activator of mTORC1, this system will allow us to transiently activate mTORC1 specifically in adipose tissue. For that, we created mice with whole body expression of caRheb under the tetracycline response element-containing promoter. We bred these animals with transgenic mice expressing reverse tetracycline-controlled transactivator (rtTA) under the adiponectin promoter. We have successfully obtained double transgenic mice that will be used to study the mTORC1 pathway in vivo.","abstract_html":"According to the CDC, approximately one third of the adults in the United States are obese consequentially causing a rise in obesity related metabolic diseases such as diabetes type 2. Major catabolic and anabolic pathways become disregulated in obesity, causing problems in energy homeostasis. One major nutrient sensor that plays an essential role in energy homeostasis is mammalian target of rapamycin complex 1 (mTORC1). mTORC1 is necessary for the proper growth and development of adipocytes. It also regulates vital adipose tissue pathways like lipolysis and lipogenesis. Therefore our lab has focused much research into better understanding mTORC1 role in energy homeostasis and how it is affected in diseases states. Previous research in our lab, using 3T3-L1 adipocytes, discovered that mTORC1 decreases mRNA levels of the lipolytic enzymes adipose triglyceride lipase (ATGL) and hormone sensitive lipase (HSL). In order to get a better picture of mTORC1&#x27;s role in lipid metabolism, we decided to create a mouse model with conditional expression of constitutively active Rheb (caRheb) in adipose tissue. As Rheb is the major activator of mTORC1, this system will allow us to transiently activate mTORC1 specifically in adipose tissue. For that, we created mice with whole body expression of caRheb under the tetracycline response element-containing promoter. We bred these animals with transgenic mice expressing reverse tetracycline-controlled transactivator (rtTA) under the adiponectin promoter. We have successfully obtained double transgenic mice that will be used to study the mTORC1 pathway in vivo.","abstract_has_math":false,"creators":["Kim, Jessica Min Joung"],"institution":"Boston University","degree_name":"Master of Arts","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2012,"date_issued":"2012","date_published":"2012","updated_at":"2026-11-18T20:28:45Z","subjects":[],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["(ALMA)contemp"],"render_values":[{"text":"(ALMA)contemp","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/12447","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/12447","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F12447","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Kim, Jessica Min Joung"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2015-08-04T20:28:29Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2015-08-04T20:28:29Z"]},{"key":"dc:date.issued","label":"Date","values":["2012"]},{"key":"dc:date.submitted","label":"Dc Date Submitted","values":["2012"]},{"key":"dc:publisher","label":"Institution","values":["Boston University"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Arts"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["(ALMA)contemp"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/12447"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (M.A.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Authorization To Manage form for this thesis or dissertation. It is therefore not openly accessible, though it may be available by request. If you are the author or principal advisor of this work and would like to request open access for it, please contact us at open-help@bu.edu. Thank you."]},{"key":"dc:description.abstract","label":"Abstract","values":["According to the CDC, approximately one third of the adults in the United States are obese consequentially causing a rise in obesity related metabolic diseases such as diabetes type 2. Major catabolic and anabolic pathways become disregulated in obesity, causing problems in energy homeostasis. One major nutrient sensor that plays an essential role in energy homeostasis is mammalian target of rapamycin complex 1 (mTORC1). mTORC1 is necessary for the proper growth and development of adipocytes. It also regulates vital adipose tissue pathways like lipolysis and lipogenesis. Therefore our lab has focused much research into better understanding mTORC1 role in energy homeostasis and how it is affected in diseases states. Previous research in our lab, using 3T3-L1 adipocytes, discovered that mTORC1 decreases mRNA levels of the lipolytic enzymes adipose triglyceride lipase (ATGL) and hormone sensitive lipase (HSL). In order to get a better picture of mTORC1's role in lipid metabolism, we decided to create a mouse model with conditional expression of constitutively active Rheb (caRheb) in adipose tissue. As Rheb is the major activator of mTORC1, this system will allow us to transiently activate mTORC1 specifically in adipose tissue. For that, we created mice with whole body expression of caRheb under the tetracycline response element-containing promoter. We bred these animals with transgenic mice expressing reverse tetracycline-controlled transactivator (rtTA) under the adiponectin promoter. We have successfully obtained double transgenic mice that will be used to study the mTORC1 pathway in vivo."]},{"key":"dc:title","label":"Title","values":["Creation of a mouse model with consitutively activated RHEB (RAS Homologue enriched in brain) in adipose tissue"]}]}],"canonical_facts":{"dc:creator":["Kim, Jessica Min Joung"],"dc:date.accessioned":["2015-08-04T20:28:29Z"],"dc:date.available":["2015-08-04T20:28:29Z"],"dc:date.issued":["2012"],"dc:date.submitted":["2012"],"dc:description":["Thesis (M.A.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Authorization To Manage form for this thesis or dissertation. It is therefore not openly accessible, though it may be available by request. If you are the author or principal advisor of this work and would like to request open access for it, please contact us at open-help@bu.edu. Thank you."],"dc:description.abstract":["According to the CDC, approximately one third of the adults in the United States are obese consequentially causing a rise in obesity related metabolic diseases such as diabetes type 2. Major catabolic and anabolic pathways become disregulated in obesity, causing problems in energy homeostasis. One major nutrient sensor that plays an essential role in energy homeostasis is mammalian target of rapamycin complex 1 (mTORC1). mTORC1 is necessary for the proper growth and development of adipocytes. It also regulates vital adipose tissue pathways like lipolysis and lipogenesis. Therefore our lab has focused much research into better understanding mTORC1 role in energy homeostasis and how it is affected in diseases states. Previous research in our lab, using 3T3-L1 adipocytes, discovered that mTORC1 decreases mRNA levels of the lipolytic enzymes adipose triglyceride lipase (ATGL) and hormone sensitive lipase (HSL). In order to get a better picture of mTORC1's role in lipid metabolism, we decided to create a mouse model with conditional expression of constitutively active Rheb (caRheb) in adipose tissue. As Rheb is the major activator of mTORC1, this system will allow us to transiently activate mTORC1 specifically in adipose tissue. For that, we created mice with whole body expression of caRheb under the tetracycline response element-containing promoter. We bred these animals with transgenic mice expressing reverse tetracycline-controlled transactivator (rtTA) under the adiponectin promoter. We have successfully obtained double transgenic mice that will be used to study the mTORC1 pathway in vivo."],"dc:identifier.other":["(ALMA)contemp"],"dc:identifier.uri":["https://hdl.handle.net/2144/12447"],"dc:language.iso":["en_US"],"dc:publisher":["Boston University"],"dc:title":["Creation of a mouse model with consitutively activated RHEB (RAS Homologue enriched in brain) in adipose tissue"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Arts"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T20:28:45Z"}